Skip to main content

Pruritus clinical trials at University of California Health

3 in progress, 1 open to eligible people

Showing trials for
  • A Study of Volixibat to Treat Itching Caused by Primary Sclerosing Cholangitis

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

    at UC Davis

  • A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)

    Sorry, not accepting new patients

    An open-label, single-arm, multi-centre program providing treatment access to ALGS patients with cholestatic pruritus in the US. Access can be requested through Clinigen Healthcare Ltd via email MirumALGS@clinigengroup.com or telephone +1-877-768-4303.

    at UCLA UCSF

  • PRISM Study-Pruritus Relief Through Itch Scratch Modulation

    Sorry, in progress, not accepting new patients

    To investigate the anti-pruritic efficacy and safety of Nalbuphine ER (NAL ER) tablets in Prurigo Nodularis. Subjects will be randomized to NAL ER (or matching placebo) with the primary endpoint evaluation at Week 14. During the open label extension, subjects who received NAL ER will continue on NAL ER and subjects who received placebo will crossover to NAL ER.

    at UCSF

Our lead scientists for Pruritus research studies include .

Last updated: